The greatest benefactor of milk thistle is the liver. It is used to improve the conditions of individuals with liver damage, inflammation, cancer, fatty liver disease, alcoholic liver disease, and hepatitis. Interestingly, it is used to defend the liver against amatoxin, found in death cap mushrooms, as well as various other toxins.
The milk thistle is has antioxidant, anticancer, and anti-inflammatory properties.
Milk thistle is perhaps helpful to bone health, researchers found that it may stimulate bone mineralization and likely reduces the risk of bone loss.
Studies have shown that milk thistle may reduce acne and improve breast milk production. Chemicals in milk thistle are thought to help individuals with diabetes, whilst the anti-inflammatory and antibiotics are believed to help prevent complications inherent with diabetes and kidney disease.
Please use moderation and care when using herbs and read our disclaimer
6784680
{6784680:T5JNIL5K},{6784680:39N4DUE8},{6784680:5QJFJGQV},{6784680:EN8MHBPA},{6784680:SW7DT4GW}
1
apa
50
default
1424
https://lae.nfa.temporary.site/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22T5JNIL5K%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BMilk%20Thistle%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20NCCIH.%20Retrieved%20August%2027%2C%202020%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.nccih.nih.gov%5C%2Fhealth%5C%2Fmilk-thistle%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.nccih.nih.gov%5C%2Fhealth%5C%2Fmilk-thistle%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Milk%20Thistle%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22This%20fact%20sheet%20provides%20basic%20information%20about%20milk%20thistle%5Cu2014common%20names%2C%20usefulness%20and%20safety%2C%20and%20resources%20for%20more%5Cu00a0information.%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nccih.nih.gov%5C%2Fhealth%5C%2Fmilk-thistle%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-27T02%3A18%3A57Z%22%7D%7D%2C%7B%22key%22%3A%2239N4DUE8%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kazazis%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKazazis%2C%20C.%20E.%2C%20Evangelopoulos%2C%20A.%20A.%2C%20Kollas%2C%20A.%2C%20%26amp%3B%20Vallianou%2C%20N.%20G.%20%282014%29.%20The%20therapeutic%20potential%20of%20milk%20thistle%20in%20diabetes.%20%26lt%3Bi%26gt%3BThe%20Review%20of%20Diabetic%20Studies%3A%20RDS%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%282%29%2C%20167%26%23x2013%3B174.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1900%5C%2FRDS.2014.11.167%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1900%5C%2FRDS.2014.11.167%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20therapeutic%20potential%20of%20milk%20thistle%20in%20diabetes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christos%20E.%22%2C%22lastName%22%3A%22Kazazis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelos%20A.%22%2C%22lastName%22%3A%22Evangelopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aris%22%2C%22lastName%22%3A%22Kollas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%20G.%22%2C%22lastName%22%3A%22Vallianou%22%7D%5D%2C%22abstractNote%22%3A%22Milk%20thistle%20has%20been%20known%20for%20more%20than%202.000%20years%20as%20a%20herbal%20remedy%20for%20a%20variety%20of%20disorders.%20It%20has%20mainly%20been%20used%20to%20treat%20liver%20and%20gallbladder%20diseases.%20Silibum%20marianum%2C%20the%20Latin%20term%20for%20the%20plant%2C%20and%20its%20seeds%20contain%20a%20whole%20family%20of%20natural%20compounds%2C%20called%20flavonolignans.%20Silimarin%20is%20a%20dry%20mixture%20of%20these%20compounds%3B%20it%20is%20extracted%20after%20processing%20with%20ethanol%2C%20methanol%2C%20and%20acetone.%20Silimarin%20contains%20mainly%20silibin%20A%2C%20silibin%20B%2C%20taxifolin%2C%20isosilibin%20A%2C%20isosilibin%20B%2C%20silichristin%20A%2C%20silidianin%2C%20and%20other%20compounds%20in%20smaller%20concentrations.%20Apart%20from%20its%20use%20in%20liver%20and%20gallbladder%20disorders%2C%20milk%20thistle%20has%20recently%20gained%20attention%20due%20to%20its%20hypoglycemic%20and%20hypolipidemic%20properties.%20Recently%2C%20a%20substance%20from%20milk%20thistle%20has%20been%20shown%20to%20possess%20peroxisome%20proliferator-activated%20receptor%20%5Cu03b3%20%28PPAR%5Cu03b3%29%20agonist%20properties.%20PPAR%5Cu03b3%20is%20the%20molecular%20target%20of%20thiazolidinediones%2C%20which%20are%20used%20clinically%20as%20insulin%20sensitizers%20to%20lower%20blood%20glucose%20levels%20in%20diabetes%20type%202%20patients.%20The%20thiazolidinedione%20type%20of%20PPAR%5Cu03b3%20ligands%20is%20an%20agonist%20with%20a%20very%20high%20binding%20affinity.%20However%2C%20this%20ligand%20type%20demonstrates%20a%20range%20of%20undesirable%20side%20effects%2C%20thus%20necessitating%20the%20search%20for%20new%20effective%20PPAR%5Cu03b3%20agonists.%20Interestingly%2C%20studies%20indicate%20that%20partial%20agonism%20of%20PPAR%5Cu03b3%20induces%20promising%20activity%20patterns%20by%20retaining%20the%20positive%20effects%20attributed%20to%20the%20full%20agonists%2C%20with%20reduced%20side%20effects.%20In%20this%20review%2C%20the%20therapeutic%20potential%20of%20milk%20thistle%20in%20the%20management%20of%20diabetes%20and%20its%20complications%20are%20discussed.%22%2C%22date%22%3A%222014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1900%5C%2FRDS.2014.11.167%22%2C%22ISSN%22%3A%221614-0575%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-27T02%3A18%3A52Z%22%7D%7D%2C%7B%22key%22%3A%225QJFJGQV%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kazazis%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKazazis%2C%20C.%20E.%2C%20Evangelopoulos%2C%20A.%20A.%2C%20Kollas%2C%20A.%2C%20%26amp%3B%20Vallianou%2C%20N.%20G.%20%282014%29.%20The%20therapeutic%20potential%20of%20milk%20thistle%20in%20diabetes.%20%26lt%3Bi%26gt%3BThe%20Review%20of%20Diabetic%20Studies%3A%20RDS%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%282%29%2C%20167%26%23x2013%3B174.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1900%5C%2FRDS.2014.11.167%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1900%5C%2FRDS.2014.11.167%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20therapeutic%20potential%20of%20milk%20thistle%20in%20diabetes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christos%20E.%22%2C%22lastName%22%3A%22Kazazis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelos%20A.%22%2C%22lastName%22%3A%22Evangelopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aris%22%2C%22lastName%22%3A%22Kollas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%20G.%22%2C%22lastName%22%3A%22Vallianou%22%7D%5D%2C%22abstractNote%22%3A%22Milk%20thistle%20has%20been%20known%20for%20more%20than%202.000%20years%20as%20a%20herbal%20remedy%20for%20a%20variety%20of%20disorders.%20It%20has%20mainly%20been%20used%20to%20treat%20liver%20and%20gallbladder%20diseases.%20Silibum%20marianum%2C%20the%20Latin%20term%20for%20the%20plant%2C%20and%20its%20seeds%20contain%20a%20whole%20family%20of%20natural%20compounds%2C%20called%20flavonolignans.%20Silimarin%20is%20a%20dry%20mixture%20of%20these%20compounds%3B%20it%20is%20extracted%20after%20processing%20with%20ethanol%2C%20methanol%2C%20and%20acetone.%20Silimarin%20contains%20mainly%20silibin%20A%2C%20silibin%20B%2C%20taxifolin%2C%20isosilibin%20A%2C%20isosilibin%20B%2C%20silichristin%20A%2C%20silidianin%2C%20and%20other%20compounds%20in%20smaller%20concentrations.%20Apart%20from%20its%20use%20in%20liver%20and%20gallbladder%20disorders%2C%20milk%20thistle%20has%20recently%20gained%20attention%20due%20to%20its%20hypoglycemic%20and%20hypolipidemic%20properties.%20Recently%2C%20a%20substance%20from%20milk%20thistle%20has%20been%20shown%20to%20possess%20peroxisome%20proliferator-activated%20receptor%20%5Cu03b3%20%28PPAR%5Cu03b3%29%20agonist%20properties.%20PPAR%5Cu03b3%20is%20the%20molecular%20target%20of%20thiazolidinediones%2C%20which%20are%20used%20clinically%20as%20insulin%20sensitizers%20to%20lower%20blood%20glucose%20levels%20in%20diabetes%20type%202%20patients.%20The%20thiazolidinedione%20type%20of%20PPAR%5Cu03b3%20ligands%20is%20an%20agonist%20with%20a%20very%20high%20binding%20affinity.%20However%2C%20this%20ligand%20type%20demonstrates%20a%20range%20of%20undesirable%20side%20effects%2C%20thus%20necessitating%20the%20search%20for%20new%20effective%20PPAR%5Cu03b3%20agonists.%20Interestingly%2C%20studies%20indicate%20that%20partial%20agonism%20of%20PPAR%5Cu03b3%20induces%20promising%20activity%20patterns%20by%20retaining%20the%20positive%20effects%20attributed%20to%20the%20full%20agonists%2C%20with%20reduced%20side%20effects.%20In%20this%20review%2C%20the%20therapeutic%20potential%20of%20milk%20thistle%20in%20the%20management%20of%20diabetes%20and%20its%20complications%20are%20discussed.%22%2C%22date%22%3A%222014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1900%5C%2FRDS.2014.11.167%22%2C%22ISSN%22%3A%221614-0575%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-27T02%3A18%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22EN8MHBPA%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Abenavoli%20et%20al.%22%2C%22parsedDate%22%3A%222010-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAbenavoli%2C%20L.%2C%20Capasso%2C%20R.%2C%20Milic%2C%20N.%2C%20%26amp%3B%20Capasso%2C%20F.%20%282010%29.%20Milk%20thistle%20in%20liver%20diseases%3A%20past%2C%20present%2C%20future.%20%26lt%3Bi%26gt%3BPhytotherapy%20Research%3A%20PTR%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%2810%29%2C%201423%26%23x2013%3B1432.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fptr.3207%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fptr.3207%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Milk%20thistle%20in%20liver%20diseases%3A%20past%2C%20present%2C%20future%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ludovico%22%2C%22lastName%22%3A%22Abenavoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raffaele%22%2C%22lastName%22%3A%22Capasso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natasa%22%2C%22lastName%22%3A%22Milic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%22%2C%22lastName%22%3A%22Capasso%22%7D%5D%2C%22abstractNote%22%3A%22Silybum%20marianum%20or%20milk%20thistle%20%28MT%29%20is%20the%20most%20well-researched%20plant%20in%20the%20treatment%20of%20liver%20disease.%20The%20active%20complex%20of%20MT%20is%20a%20lipophilic%20extract%20from%20the%20seeds%20of%20the%20plant%20and%20is%20composed%20of%20three%20isomer%20flavonolignans%20%28silybin%2C%20silydianin%2C%20and%20silychristin%29%20collectively%20known%20as%20silymarin.%20Silybin%20is%20a%20component%20with%20the%20greatest%20degree%20of%20biological%20activity%20and%20makes%20up%2050%25%20to%2070%25%20of%20silymarin.%20Silymarin%20is%20found%20in%20the%20entire%20plant%20but%20it%20is%20concentrated%20in%20the%20fruit%20and%20seeds.%20Silymarin%20acts%20as%20an%20antioxidant%20by%20reducing%20free%20radical%20production%20and%20lipid%20peroxidation%2C%20has%20antifibrotic%20activity%20and%20may%20act%20as%20a%20toxin%20blockade%20agent%20by%20inhibiting%20binding%20of%20toxins%20to%20the%20hepatocyte%20cell%20membrane%20receptors.%20In%20animals%2C%20silymarin%20reduces%20liver%20injury%20caused%20by%20acetaminophen%2C%20carbon%20tetrachloride%2C%20radiation%2C%20iron%20overload%2C%20phenylhydrazine%2C%20alcohol%2C%20cold%20ischaemia%20and%20Amanita%20phalloides.%20Silymarin%20has%20been%20used%20to%20treat%20alcoholic%20liver%20disease%2C%20acute%20and%20chronic%20viral%20hepatitis%20and%20toxin-induced%20liver%20diseases.%22%2C%22date%22%3A%22Oct%202010%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fptr.3207%22%2C%22ISSN%22%3A%221099-1573%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-27T02%3A18%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22SW7DT4GW%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BMilk%20Thistle%3A%20Benefits%20and%20Side%20Effects%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20WebMD.%20Retrieved%20August%2027%2C%202020%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.webmd.com%5C%2Fdigestive-disorders%5C%2Fmilk-thistle-benefits-and-side-effects%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.webmd.com%5C%2Fdigestive-disorders%5C%2Fmilk-thistle-benefits-and-side-effects%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Milk%20Thistle%3A%20Benefits%20and%20Side%20Effects%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22WebMD%20examines%20the%20use%20of%20milk%20thistle%20to%20lower%20cholesterol%2C%20treat%20liver%20problems%2C%20and%20benefit%20diabetes.%20Does%20it%20work%3F%22%2C%22date%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.webmd.com%5C%2Fdigestive-disorders%5C%2Fmilk-thistle-benefits-and-side-effects%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-27T02%3A18%3A29Z%22%7D%7D%5D%7D
Milk Thistle. (n.d.). NCCIH. Retrieved August 27, 2020, from https://www.nccih.nih.gov/health/milk-thistle
Kazazis, C. E., Evangelopoulos, A. A., Kollas, A., & Vallianou, N. G. (2014). The therapeutic potential of milk thistle in diabetes. The Review of Diabetic Studies: RDS, 11(2), 167–174. https://doi.org/10.1900/RDS.2014.11.167
Kazazis, C. E., Evangelopoulos, A. A., Kollas, A., & Vallianou, N. G. (2014). The therapeutic potential of milk thistle in diabetes. The Review of Diabetic Studies: RDS, 11(2), 167–174. https://doi.org/10.1900/RDS.2014.11.167
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010). Milk thistle in liver diseases: past, present, future. Phytotherapy Research: PTR, 24(10), 1423–1432. https://doi.org/10.1002/ptr.3207
Milk Thistle: Benefits and Side Effects. (n.d.). WebMD. Retrieved August 27, 2020, from https://www.webmd.com/digestive-disorders/milk-thistle-benefits-and-side-effects